Patent: 10,087,493
✉ Email this page to a colleague
Summary for Patent: 10,087,493
| Title: | Method for detecting infectious parvovirus in pharmaceutical preparations |
| Abstract: | The present invention provides methods for detecting viral infectivity and content in an enzyme preparation. In certain embodiments, the invention relates to methods for producing a pharmaceutical pancreatic enzyme composition. In additional embodiments, the invention relates to detecting infectious porcine parvovirus (PPV) and determining PPV content in pancreatic enzyme preparations (PEPs), including pancrelipase preparations. |
| Inventor(s): | Tijssen; Peter (Pointe-Claire, CA), Szelei; Jozsef (Laval, CA), Zadori; Zoltan (Montreal, CA) |
| Assignee: | APTALIS PHARMA CANADA ULC (CA) |
| Application Number: | 12/400,145 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,087,493
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | December 09, 1996 | 10,087,493 | 2029-03-09 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | April 30, 2009 | 10,087,493 | 2029-03-09 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | June 10, 2011 | 10,087,493 | 2029-03-09 |
| Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | March 14, 2013 | 10,087,493 | 2029-03-09 |
| Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | May 17, 2012 | 10,087,493 | 2029-03-09 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
